Aclarion joins PRISM Emerging Medical Devices Index

Aclarion, Inc. has been added to the PRISM Emerging Medical Devices Index, highlighting its innovative AI-driven diagnostic solutions for chronic low back pain. The global medical devices market is projected to reach nearly $315 billion by 2032, with lumbar spine diagnostics alone estimated at $40 billion annually. Aclarion's NOCISCAN technology offers a noninvasive method to identify painful discs, addressing significant healthcare costs associated with lower back pain.